A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

Journal of Clinical Oncology

Volumn 10, Issue 1, 1992, Pages 102-110

  Antman, K ^a   Ayash, L ^a   Elias, A ^a   Wheeler, C ^a   Hunt, M ^a   Eder, J P ^a   Teicher, B A ^a   Critchlow, J ^a   Bibbo, J ^a   Schnipper, L E ^a   Frei III, E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; THIOTEPA;

ADULT; ADVANCED CANCER; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLEEDING; BREAST CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REGIONAL PERFUSION; SURVIVAL;

EID: 0026558969     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.1.102     Document Type: Conference Paper

References (0)